Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Health and Human Services Department. "Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines / U.S. Department of Health and Human Services ; Prepared by the Office of the Assistant Secretary for Planning and Evaluation". Government. Health and Human Services Department, January 1, 2022. https://www.govinfo.gov/app/details/GOVPUB-HE-PURL-gpo213242
Health and Human Services Department. (2022, January 1). Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines / U.S. Department of Health and Human Services ; Prepared by the Office of the Assistant Secretary for Planning and Evaluation. [Government]. Health and Human Services Department. https://www.govinfo.gov/app/details/GOVPUB-HE-PURL-gpo213242
Health and Human Services Department. Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines / U.S. Department of Health and Human Services ; Prepared by the Office of the Assistant Secretary for Planning and Evaluation. Health and Human Services Department, (1 Jan 2022), https://www.govinfo.gov/app/details/GOVPUB-HE-PURL-gpo213242
Health and Human Services Department, Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines / U.S. Department of Health and Human Services ; Prepared by the Office of the Assistant Secretary for Planning and Evaluation, GovInfo, (January 1, 2022), https://www.govinfo.gov/app/details/GOVPUB-HE-PURL-gpo213242